Association of tumor infiltrating lymphocyte quantity with survival in patients (pts) with metastatic breast cancer (MBC) receiving microtubule-targeting agents: Post hoc analysis CALGB 40502 (Alliance).
         Google Scholar   
Citation:
J Clin Oncol vol 41 (suppl 16) 1010
Meeting Instance:
ASCO 2023
Year:
2023
Type:
Abstract
Sub type:
Published Only
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epreprint
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
4154  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
BMS, Celgene  
Grants:
U10CA180821, U10CA180882  
Corr. Author:
 
Authors:
                                 
Networks:
CA824, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-OH007, LAPS-TX035   
Study
CALGB-40502
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: